In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.
Discover how targeted red and near-infrared light therapies influence mitochondrial biology, cellular repair pathways, and emerging clinical treatments across multiple health systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results